Role of the bile salt export pump, BSEP, in acquired forms of cholestasis
- PMID: 20028269
- DOI: 10.3109/03602530903492004
Role of the bile salt export pump, BSEP, in acquired forms of cholestasis
Abstract
Generation of bile is a key function of the liver. Its impairment leads to accumulation of cytotoxic bile salts in hepatocytes and, consequently, to liver disease. The bile salt export pump, BSEP, is critically involved in the secretion of bile salts into bile. Its function can be disturbed or abolished by inherited mutations. This will lead to progressive intrahepatic cholestais and severe liver disease. In addition to mutations, BSEP can be inhibited by acquired factors, such as xenobiotics or drugs, aberrant bile salt metabolites, or pregnancy. This inhibition will lead to acquired cholestasis. Some drugs are now known to be competitive inhibitors of Bsep. In addition, a polymorphism in the gene coding for BSEP has been identified as a potential susceptibility factor for acquired cholestasis.
Similar articles
-
The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.Handb Exp Pharmacol. 2011;(201):205-59. doi: 10.1007/978-3-642-14541-4_5. Handb Exp Pharmacol. 2011. PMID: 21103971 Review.
-
Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy.Semin Liver Dis. 2010 May;30(2):147-59. doi: 10.1055/s-0030-1253224. Epub 2010 Apr 26. Semin Liver Dis. 2010. PMID: 20422497 Review.
-
The bile salt export pump.Pflugers Arch. 2007 Feb;453(5):611-20. doi: 10.1007/s00424-006-0152-8. Epub 2006 Oct 19. Pflugers Arch. 2007. PMID: 17051391 Review.
-
Recent advances in the exploration of the bile salt export pump (BSEP/ABCB11) function.Expert Opin Ther Targets. 2016;20(4):501-14. doi: 10.1517/14728222.2016.1102889. Epub 2015 Nov 17. Expert Opin Ther Targets. 2016. PMID: 26573700 Review.
-
The bile salt export pump: molecular properties, function and regulation.Pflugers Arch. 2004 Nov;449(2):123-31. doi: 10.1007/s00424-004-1311-4. Epub 2004 Jul 24. Pflugers Arch. 2004. PMID: 15578267 Review.
Cited by
-
Rho-kinase/myosin light chain kinase pathway plays a key role in the impairment of bile canaliculi dynamics induced by cholestatic drugs.Sci Rep. 2016 May 12;6:24709. doi: 10.1038/srep24709. Sci Rep. 2016. PMID: 27169750 Free PMC article.
-
Farnesoid X Receptor as Target for Therapies to Treat Cholestasis-Induced Liver Injury.Cells. 2021 Jul 21;10(8):1846. doi: 10.3390/cells10081846. Cells. 2021. PMID: 34440614 Free PMC article. Review.
-
Untargeted Metabolomic Analysis Combined With Multivariate Statistics Reveal Distinct Metabolic Changes in GPR40 Agonist-Treated Animals Related to Bile Acid Metabolism.Front Mol Biosci. 2021 Jan 15;7:598369. doi: 10.3389/fmolb.2020.598369. eCollection 2020. Front Mol Biosci. 2021. PMID: 33521051 Free PMC article.
-
Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice.Antioxidants (Basel). 2021 Mar 5;10(3):390. doi: 10.3390/antiox10030390. Antioxidants (Basel). 2021. PMID: 33807700 Free PMC article. Review.
-
Mechanisms of Hepatic Cholestatic Drug Injury.J Clin Transl Hepatol. 2019 Mar 28;7(1):86-92. doi: 10.14218/JCTH.2018.00042. Epub 2019 Mar 25. J Clin Transl Hepatol. 2019. PMID: 30944824 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources